In celebration of November’s Native American Heritage Month and Stomach Cancer Awareness Month observances, the John Wayne Cancer Foundation is funding research that will allow doctors to assess barriers to treatment of H. pylori and disseminate findings to community health partners to reduce the occurrence of stomach cancer.
Perioperative treatment with Imfinzi (durvalumab) in combination with standard-of-care FLOT (fluorouracil, leucovorin, oxaliplatin, and docetaxel) chemotherapy demonstrated a statistically significant and clinically meaningful improvement in the key secondary endpoint of overall survival versus chemotherapy alone, according to MATTERHORN phase III trial results.
